Q&A: How ar­genx’s CEO plans to cre­ate a se­quel to Vyv­gart (and beat the IRA)

Tim Van Hauw­er­meiren is one of Eu­rope’s most suc­cess­ful biotech en­tre­pre­neurs, hav­ing turned a €1 mil­lion in­vest­ment cri­sis in­to a drug com­pa­ny worth more than …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER